GENE ONLINE|News &
Opinion
Blog

Base Editing
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Singapore Researchers Design New C to G Base Editor to Correct Disease-Associated Mutations
2021-03-18
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
New and Improved Base-Editing Tool Helps Cure Blindness in Mice
2020-10-25
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Base Editing the Cell’s Powerhouse: Bacterial Toxin Could Help Cure Mitochondrial Diseases
2020-07-26
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Successful Gene-Editing to Reverse Deafness Scores Another Win for Gene Therapy
2020-06-07
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
Evolved Base Editor Surpasses Predecessors with High Efficiency and Versatility
2020-03-18
Base Editing Start-up Beams with US$180 Million IPO
2020-02-06
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
Prime Editing: A New Twist in the CRISPR Tale
2019-11-28
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top